Dabrafenib mesylate Pharmacy Grade
1195768-06-9
Pharmaceutical Grade
99%
SHANGHAI
25kg/Cardboard Drum
2019-07-07
Anti-tumor categories,Cardiovascular,Anti-Diabetes Class,4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one,4-Amino-3-chlorophenol hydrochloride,4-Amino-3-chlorophenol
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Dabrafenib mesylate
Other Name:Benzenesulfonamide,N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-,methanesulfonate (1:1);Dabrafenib mesylate;GSK 2118436 methanesulfonate salt;GSK 2118436B;N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid
CAS No.:1195768-06-9
Molecular Formula:C23H20F3N5O2S2.CH4O3S
InChIKeys:InChIKey=YKGMKSIHIVVYKY-UHFFFAOYSA-N
Molecular Weight:615.6680696
Exact Mass:615.089
EC Number:1592732-453-0
UNII:B6DC89I63E
DSSTox ID:DTXSID70152500
NCI Thesaurus Code:C128059
ATC Code:L01EC02
Categories:
Characteristics-
PSA:
210
XLogP3:7.03360
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Serious eye damage, Category 1
Carcinogenicity, Category 2
Reproductive toxicity, Category 2
Specific target organ toxicity â repeated exposure, Category 2
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H315 Causes skin irritation
H318 Causes serious eye damage
H351 Suspected of causing cancer
H361 Suspected of damaging fertility or the unborn child
H373 May cause damage to organs through prolonged or repeated exposure
H400 Very toxic to aquatic life
H411 Toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P273 Avoid release to the environment.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Anti-tumor categories,Cardiovascular,Anti-Diabetes Class,4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one,4-Amino-3-chlorophenol hydrochloride,4-Amino-3-chlorophenol
-
Location:
No.9 Weidi Road-Jiangsu Life Science and Technology Innovation Park, Nanjing, P.R.C
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
7
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2008
-
Certifications:
business license
Nanjing CHICO Pharmaceutical Co., Ltd is a high-tech enterprise specializing in R&D, production and sales of APIs and pharmaceutical intermediates. We are recognized as National High-Tech Enterprises by Science and Technology Department of Jiangsu Province in 2014.Adhering to the "Consummate service Convincing honor" business strategy, CHICO will provide you the qualified products and first-class service which are based on our strong technical accumulation and outstanding professionalism.
CHICO was established in July 2008, our sales office and R&D center is located in No.9 Weidi Road -Jiangsu life science and Technology Innovation Park, covering an area of about 1800 square meters. Our GMP factory is located in AnQing--- AnQing CHICO pharmaceutical Co., LTD, with a total area of 20000 square meters. Meanwhile, we also have set our cooperative production base in Huai’an. Now we have a complete ,stable production chain of gram-kilogram-ton so that we can achieve rapid response in the whole R&D-scale up- producing process for new products at the first time.
We always regard the quality as life, thus we have established our quality department which is directly controlled by GM. Also we have set a perfect quality assurance system and strict quality control standards according to the GMP requirements' and we have already passed the ISO 9001 quality system certification.
We warmly thank the new and old customers that support and cooperate with us. We sincerely look forward to using "integrity, quality, efficient, professional" service to enhance mutual friendship and create brilliance hand in hand with you!
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
